Maeta M, Sugesawa A, Ikeguchi M, Tsujitani S, Yamashiro H, Shibata S, Kondo A, Kaibara N
First Department of Surgery, Tottori University School of Medicine, Yonago, Japan.
Surg Today. 1994;24(1):40-3. doi: 10.1007/BF01676883.
For patients with gastric cancer and either P1 or P2 peritoneal metastasis, no definite consistent policy with respect to the extent of lymph node dissection has yet been established. In palliatively gastrectomized patients, we analyzed the relationship between the extent of lymphadenectomy and postoperative survival. In patients with P1, an R2 or R3 lymphadenectomy was associated with a significantly improved postoperative survival as compared to an R1 dissection, while this, however, was not the case in patients with P2. As this study was not intended to be a prospective randomized study, a definite conclusion should be avoided. However, our findings suggest that in patients with P1, surgery should not be confined to a resection of the primary lesion, but should also include an R2 or R3 lymphadenectomy.
对于患有胃癌且伴有P1或P2腹膜转移的患者,关于淋巴结清扫范围尚未确立明确一致的策略。在接受姑息性胃切除的患者中,我们分析了淋巴结清扫范围与术后生存之间的关系。在P1患者中,与R1清扫相比,R2或R3淋巴结清扫与术后生存显著改善相关,然而,在P2患者中并非如此。由于本研究并非旨在进行前瞻性随机研究,应避免得出明确结论。然而,我们的研究结果表明,对于P1患者,手术不应局限于切除原发灶,还应包括R2或R3淋巴结清扫。